P53 sous le soleil

Thierry Magnaldo

doi:10.1051/medsci/20072367581

Accueil

Tous les numéros

Volume 23 / Numéro 6-7 (Juin-Juillet 2007)

Med Sci (Paris), 23 6-7 (2007) 581-583

Références

Accès gratuit

Numéro		Med Sci (Paris) Volume 23, Numéro 6-7, Juin-Juillet 2007


Page(s)		581 - 583
Section		Nouvelles
DOI		https://doi.org/10.1051/medsci/20072367581
Publié en ligne		15 juin 2007

Cui R, Widlund HR, Feige E, et al. Central role of p53 in the suntan response and pathologic hyperpigmentation. Cell 2007; 128 : 853–64. [Google Scholar]
Linzer DI, Levine AJ. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 1979; 17 : 43–52. [Google Scholar]
Lane DP, Crawford LV. T antigen is bound to a host protein in SV40-transformed cells. Nature 1979; 278 : 261–3. [Google Scholar]
Kress M, May E, Cassingena R, May P. Simian virus 40-transformed cells express new species of proteins precipitable by anti-simian virus 40 tumor serum. J Virol 1979; 31 : 472–83. [Google Scholar]
Lane DP. Cancer. p53, guardian of the genome. Nature 1992; 358 : 15–6. [Google Scholar]
Toledo F, Bluteau O, Simeonova I. Réactivation de p53 dans les tumeurs : une stratégie antitumorale prometteuse. Med Sci (Paris) 2007; 23 : 565–7. [Google Scholar]
Magnaldo T. La «guerre» du NER (nucleotide excision repair). Med Sci (Paris) 2004; 20 : 268–70. [Google Scholar]
Adimoolam S, Ford JM. p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene. Proc Natl Acad Sci USA 2002; 99 : 12985–90. [Google Scholar]
Hoeijmakers JH. Genome maintenance mechanisms for preventing cancer. Nature 2001; 411 : 366–74. [Google Scholar]
Polyak K, Xia Y, Zweier JL, et al. A model for p53-induced apoptosis. Nature 1997; 389 : 300–5. [Google Scholar]
Sablina AA, Budanov AV, Ilyinskaya GV, et al. The antioxidant function of the p53 tumor suppressor. Nat Med 2005; 11 : 1306–13. [Google Scholar]
Miyamura Y, Coelho SG, Wolber R, et al. Regulation of human skin pigmentation and responses to ultraviolet radiation. Pigment Cell Res 2007; 20 : 2–13. [Google Scholar]
Khlgatian MK, Hadshiew IM, Asawanonda P, et al. Tyrosinase gene expression is regulated by p53. Jof Inv Dermatol 2002; 118 : 126–32. [Google Scholar]
Bartkova J, Horejsi Z, Koed K, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 2005; 434 : 864–70. [Google Scholar]
Bendesky A, Rosales A, Salazar AM, et al. p53 codon 72 polymorphism, DNA damage and repair, and risk of non-melanoma skin cancer. Mutat Res 2007; 619 : 38–44. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.

[1] Cui R, Widlund HR, Feige E, et al. Central role of p53 in the suntan response and pathologic hyperpigmentation. Cell 2007; 128 : 853–64. [Google Scholar]

[2] Linzer DI, Levine AJ. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 1979; 17 : 43–52. [Google Scholar]

[3] Lane DP, Crawford LV. T antigen is bound to a host protein in SV40-transformed cells. Nature 1979; 278 : 261–3. [Google Scholar]

[4] Kress M, May E, Cassingena R, May P. Simian virus 40-transformed cells express new species of proteins precipitable by anti-simian virus 40 tumor serum. J Virol 1979; 31 : 472–83. [Google Scholar]

[5] Lane DP. Cancer. p53, guardian of the genome. Nature 1992; 358 : 15–6. [Google Scholar]

[6] Toledo F, Bluteau O, Simeonova I. Réactivation de p53 dans les tumeurs : une stratégie antitumorale prometteuse. Med Sci (Paris) 2007; 23 : 565–7. [Google Scholar]

[7] Magnaldo T. La «guerre» du NER (nucleotide excision repair). Med Sci (Paris) 2004; 20 : 268–70. [Google Scholar]

[8] Adimoolam S, Ford JM. p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene. Proc Natl Acad Sci USA 2002; 99 : 12985–90. [Google Scholar]

[9] Hoeijmakers JH. Genome maintenance mechanisms for preventing cancer. Nature 2001; 411 : 366–74. [Google Scholar]

[10] Polyak K, Xia Y, Zweier JL, et al. A model for p53-induced apoptosis. Nature 1997; 389 : 300–5. [Google Scholar]

[11] Sablina AA, Budanov AV, Ilyinskaya GV, et al. The antioxidant function of the p53 tumor suppressor. Nat Med 2005; 11 : 1306–13. [Google Scholar]

[12] Miyamura Y, Coelho SG, Wolber R, et al. Regulation of human skin pigmentation and responses to ultraviolet radiation. Pigment Cell Res 2007; 20 : 2–13. [Google Scholar]

[13] Khlgatian MK, Hadshiew IM, Asawanonda P, et al. Tyrosinase gene expression is regulated by p53. Jof Inv Dermatol 2002; 118 : 126–32. [Google Scholar]

[14] Bartkova J, Horejsi Z, Koed K, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 2005; 434 : 864–70. [Google Scholar]

[15] Bendesky A, Rosales A, Salazar AM, et al. p53 codon 72 polymorphism, DNA damage and repair, and risk of non-melanoma skin cancer. Mutat Res 2007; 619 : 38–44. [Google Scholar]